Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Chazerain

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Joint Bone Spine|July 6, 2023
Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohortLéa Perrot, Laurent Boyer, René-Marc Flipo, et al.
Joint Bone Spine|April 26, 2003
Prognostic value of early computed tomography in radiculopathy due to lumbar intervertebral disk herniation. A prospective studyCatherine Beauvais, Marc Wybier, Pascal Chazerain, et al.
Joint Bone Spine|July 3, 2023
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent wavesElodie Drumez, Christophe Richez, Louis Bebear, et al.
RMD Open|May 10, 2022
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseasesRim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, et al.
Joint Bone Spine|November 23, 2023
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitisChristelle Darrieutort-Laffite, Guillaume Coiffier, Florence Aïm, et al.
The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.
Frontiers in Medicine|April 10, 2023
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseasesKevin Chevalier, Michaël Genin, Thomas Petit Jean, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 1, 2024
Clinical features and treatment outcomes of bone and joint nontuberculous mycobacterial infections according to immune status: a 9-year retrospective observational cohortPascale Bémer, Alexandra Aubry, Frédéric Schramm, et al.
RMD Open|January 6, 2025
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort studyFélicien Triboulet, Pierre-Antoine Juge, Marie-Elise Truchetet, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Joint Bone Spine|July 6, 2023
Factors associated with COVID-19 severity in patients with spondyloarthritis: Results of the French RMD COVID-19 cohortLéa Perrot, Laurent Boyer, René-Marc Flipo, et al.
Joint Bone Spine|April 26, 2003
Prognostic value of early computed tomography in radiculopathy due to lumbar intervertebral disk herniation. A prospective studyCatherine Beauvais, Marc Wybier, Pascal Chazerain, et al.
Joint Bone Spine|July 3, 2023
Comparing COVID-19 disease severity in patients with rheumatic and inflammatory diseases between the first and the subsequent wavesElodie Drumez, Christophe Richez, Louis Bebear, et al.
RMD Open|May 10, 2022
COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseasesRim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, et al.
Joint Bone Spine|November 23, 2023
2023 French recommendations for diagnosing and managing prepatellar and olecranon septic bursitisChristelle Darrieutort-Laffite, Guillaume Coiffier, Florence Aïm, et al.
The Lancet. Rheumatology|March 31, 2021
COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort studyJérôme Avouac, Elodie Drumez, Eric Hachulla, et al.
Frontiers in Medicine|April 10, 2023
CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseasesKevin Chevalier, Michaël Genin, Thomas Petit Jean, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|June 1, 2024
Clinical features and treatment outcomes of bone and joint nontuberculous mycobacterial infections according to immune status: a 9-year retrospective observational cohortPascale Bémer, Alexandra Aubry, Frédéric Schramm, et al.
RMD Open|January 6, 2025
Evaluation of rheumatoid arthritis-associated interstitial lung disease in patients treated with JAK inhibitors: a MAJIK-SFR cohort studyFélicien Triboulet, Pierre-Antoine Juge, Marie-Elise Truchetet, et al.
The Lancet. Rheumatology|November 15, 2021
Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort studySebastian E Sattui, Richard Conway, Michael S Putman, et al.
Pageof 2